AP News
COVID vaccine developer BioNTech sees profits rise – BERLIN (AP) – German pharmaceutical company BioNTech, which partnered with Pfizer to develop the first widely used COVID-19 vaccine, said Tuesday that its earnings grew again in the third quarter.BioNTech, which is based in Mainz, reported a net profit of more than 3.2 billion euros ($3.7 billion) for the July-September …
